Inhibikase Back In Game As FDA Lifts Hold On Multiple System Atrophy Drug

The US FDA lifted a clinical hold that it had placed in November after reviewing the company’s INDs to start Phase IIa studies in MSA and Parkinson’s, which was the subject of a hold lifted in January.